Cash on Hand for Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's latest reported cash and short-term investments is $3.26B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$3.26B
YoY change
+81.5%
5Y CAGR
-0.4%
Peak year (2020)
$10.32B
Latest annual
$10.11B
Cash on Hand history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Cash on Hand history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $10.11B | +81.5% | ||
| 2024 | $5.57B | -31.1% | ||
| 2023 | $8.08B | -5.2% | ||
| 2022 | $8.52B | +90.4% | ||
| 2021 | $4.48B | -56.6% | ||
| 2020 | $10.32B | +330.4% | ||
| 2019 | $2.40B | +14.1% | ||
| 2018 | $2.10B | +57.5% | ||
| 2017 | $1.33B | +69.8% | ||
| 2016 | $786.00M | +73.9% | ||
| 2015 | $452.10M | -66.3% | ||
| 2014 | $1.34B | -77.0% | ||
| 2013 | $5.83B | +619.9% | ||
| 2012 | $809.90M | -20.6% | ||
| 2011 | $1.02B | +10.2% | ||
| 2010 | $926.00M | -41.1% | ||
| 2009 | $1.57B | +22.0% | ||
| 2008 | $1.29B | +101.5% | ||
| 2007 | $639.20M | -7.5% | ||
| 2006 | $691.20M | +134.3% | ||
| 2005 | $294.99M | -42.4% | ||
| 2004 | $512.25M | +22.5% | ||
| 2003 | $418.24M | -52.2% | ||
| 2002 | $875.47M | -16.0% | ||
| 2001 | $1.04B | +1.5% | ||
| 2000 | $1.03B | +22.6% | ||
| 1999 | $838.00M | -45.9% | ||
| 1998 | $1.55B | +1.6% | ||
| 1997 | $1.52B | -17.5% | ||
| 1996 | $1.85B | +74.8% | ||
| 1995 | $1.06B | +175.9% | ||
| 1994 | $382.80M | +17.5% | ||
| 1993 | $325.70M | +70.9% | ||
| 1992 | $190.60M | +45.5% | ||
| 1991 | $131.00M | +11.1% | ||
| 1990 | $117.90M | +25.6% | ||
| 1989 | $93.90M | -31.2% | ||
| 1988 | $136.40M | -5.3% | ||
| 1987 | $144.10M | +125.9% | ||
| 1986 | $63.80M | +112.7% | ||
| 1985 | $30.00M | — |
Cash on Hand values are taken from Thermo Fisher Scientific's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Thermo Fisher Scientific (TMO) cash and short-term investments is $10.11B – surged 81.5% year-over-year.
Thermo Fisher Scientific cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is -0.4%, with a net decline across the window.
Thermo Fisher Scientific cash and short-term investments peaked at $10.32B in 2020; the latest annual figure is $10.11B in 2025 (2.1% below peak).
$10.32B stands as the all-time-high annual cash and short-term investments, posted in 2020, against a low of $30.00M during 1985.
Within Healthcare, Thermo Fisher Scientific (TMO) ranks 5th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
Thermo Fisher Scientific Cash on Hand by Year
Thermo Fisher Scientific Cash on Hand 2025: $10.11B
Thermo Fisher Scientific cash and short-term investments in 2025 was $10.11B, surged 81.5% from 2024.
Thermo Fisher Scientific Cash on Hand 2024: $5.57B
Thermo Fisher Scientific cash and short-term investments in 2024 was $5.57B, plunged 31.1% below 2023.
Thermo Fisher Scientific Cash on Hand 2023: $8.08B
Thermo Fisher Scientific cash and short-term investments in 2023 was $8.08B, declined 5.2% below 2022.
Thermo Fisher Scientific Cash on Hand 2022: $8.52B
Thermo Fisher Scientific cash and short-term investments in 2022 was $8.52B, surged 90.4% from 2021.
Thermo Fisher Scientific Cash on Hand 2021: $4.48B
Thermo Fisher Scientific cash and short-term investments in 2021 was $4.48B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers — Cash on Hand
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Thermo Fisher Scientific's cash and short-term investments?
- Latest reported cash and short-term investments for Thermo Fisher Scientific (TMO) is $3.26B (period ending March 28, 2026).
How has Thermo Fisher Scientific cash and short-term investments changed year-over-year?
- Thermo Fisher Scientific (TMO) cash and short-term investments changed +81.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Thermo Fisher Scientific cash and short-term investments?
- Thermo Fisher Scientific (TMO) cash and short-term investments compound annual growth rate is -0.4% over the most recent 5 years available.
When did Thermo Fisher Scientific cash and short-term investments hit its highest annual value?
- Thermo Fisher Scientific cash and short-term investments reached its highest annual value of $10.32B in 2020.
What was Thermo Fisher Scientific cash and short-term investments in 2024?
- Thermo Fisher Scientific (TMO) cash and short-term investments in 2024 was $5.57B.
What was Thermo Fisher Scientific cash and short-term investments in 2025?
- Thermo Fisher Scientific (TMO) cash and short-term investments in 2025 was $10.11B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TMO Overview
Company profile, financial tools, and key metrics
TMO Revenue Counter
Earns $1,433 every second. See per minute, hour, and day.
TMO Earnings Counter
Earns $217.50 per second net profit. See per minute, hour, and day.
TMO Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
TMO What If Invested
What if you had invested $1,000? See historical returns from any date.
TMO How It Makes Money
Discover visual breakdown of $45.20B in revenue — where it comes from and where it goes.
TMO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TMO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TMO Daily Price Character
Balanced · 47.1% historical win rate (green days). Streaks & record days.
TMO Buybacks
4.54% TTM buyback yield. Shareholder yield & SBC comparison.
TMO Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
TMO Dividend Profile
Yield: 0.38%. Safety: 5/8. See full history.
TMO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TMO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.